Abstract:Precise spatiotemporal control of gene expression patterns is critical for normal development. Pluripotent stem cells, including embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), with the ability of unlimited self-renewal and differentiation into any cell type, provide a unique tool for understanding the underlying mechanism of development and disease in a dish. N6-methyl-adenosine (m6A) modification is the most extensive internal mRNA modification, which regulates almost all aspects of mRNA metabolism and thus extensively participates in gene expression regulation. However, the role of m6A during cardiogenesis still needs to be fully elucidated. Here, we found that core components of m6A methyltransferase decreased during cardiomyocyte differentiation. Impeding m6A deposition, by either deleting the m6A methyltransferase Mettl3 or overexpressing m6A demethylase alkB homolog 5 (Alkbh5), at early stages of cardiac differentiation of mouse pluripotent stem cells, led to inhibition of cardiac gene activation and retardation of the outgrowth of embryoid bodies, whereas interfering m6A modification at later stages of differentiation had minimal effects. Consistently, stage-specific inhibition of METTL3 with METTL3 inhibitor STM2457 during human ESCs (hESCs) cardiac differentiation demonstrated a similarly pivotal role of METTL3 for the induction of mesodermal cells while dispensable function for later stages. In summary, our study reveals a stage-specific requirement of m6A on the cardiac differentiation of pluripotent stem cells and demonstrates that precise tuning of m6A level is critical for cardiac differentiation.

m6A mRNA methylation by METTL14 regulates early pancreatic cell differentiation

N 6 -Methyladenosine Modification-Mediated Mrna Metabolism is Essential for Human Pancreatic Lineage Specification and Islet Organogenesis

N6-methyladenosine modification-mediated mRNA metabolism is essential for human pancreatic lineage specification and islet organogenesis

m6A mRNA Methylation Controls Functional Maturation in Neonatal Murine β-Cells

A METTL3–METTL14 Complex Mediates Mammalian Nuclear RNA N 6 -Adenosine Methylation

Rna N-6-Methyladenosine Methylation In Post-Transcriptional Gene Expression Regulation

M6a-Binding Proteins: the Emerging Crucial Performers in Epigenetics

The emerging roles of N6-methyladenosine RNA methylation in human cancers

Mettl3-Mediated M6a Methylation Controls Pancreatic Bipotent Progenitor Fate and Islet Formation.

Arginine Methylation of METTL14 Promotes RNA N6-methyladenosine Modification and Endoderm Differentiation of Mouse Embryonic Stem Cells.

M(6)a RNA Modification Controls Cell Fate Transition in Mammalian Embryonic Stem Cells.

Research advances of N6‐methyladenosine in diagnosis and therapy of pancreatic cancer

Stage-specific requirement for m6A RNA methylation during cardiac differentiation of pluripotent stem cells

The 18S rRNA m 6 A methyltransferase METTL 5 promotes mouse embryonic stem cell differentiation

M6 A Mrna Methylation: Biological Features, Mechanisms, and Therapeutic Potentials in Type 2 Diabetes Mellitus.

M6a Regulates Neurogenesis and Neuronal Development by Modulating Histone Methyltransferase Ezh2

m(6)A RNA methylation is regulated by microRNAs and promotes reprogramming to pluripotency

N6-Methyladenosine Methyltransferases and Demethylases: New Regulators of Stem Cell Pluripotency and Differentiation

Regulation of RNA N6-methylation of adenosine on stem cell differentiation

Role of N6-methyl-adenosine Modification in Mammalian Embryonic Development

Mettl14-Mediated M6a Modification Facilitates Liver Regeneration by Maintaining Endoplasmic Reticulum Homeostasis